Brought to you by 
Xtent nets $67.8mm with IPO
16 Oct 2007
Executive Summary
Xtent (drug-eluting systems for coronary artery disease) has netted $67.8mm
through the initial public offering of 4.7mm common shares priced at $16 each, the low end of its anticipated $16-18 range.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com